Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Neoplasm in the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03830385
What this trial is testing

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Sun Yat-sen University 51
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Testing effectiveness (Phase 2)Study completedNCT01684098
What this trial is testing

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Who this might be right for
Recurrent or Metastatic CancerHead and Neck CancerPancreas Cancer+2 more
Endocyte 40
Large-scale testing (Phase 3)Looking for participantsNCT07217704
What this trial is testing

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Who this might be right for
Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction
SOFIE 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388758
What this trial is testing

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 37
Not applicableUnknownNCT00173849
What this trial is testing

The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma

Who this might be right for
Oral Cancer
National Taiwan University Hospital 100
Early research (Phase 1)Looking for participantsNCT06886347
What this trial is testing

Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Chen Xiaozhong 47
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)UnknownNCT01830504
What this trial is testing

Phase II Pilot Open Label

Who this might be right for
Thyroid Cancers
Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Study completedNCT03109158
What this trial is testing

NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
NanoCarrier Co., Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT01040832
What this trial is testing

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck Cancer
EMD Serono 107
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Not applicableStudy completedNCT05303740
What this trial is testing

Anlotinib Retrospective Study for Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Feng Wang 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06933966
What this trial is testing

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaNon Metastatic Disease
Centre Leon Berard 120
Early research (Phase 1)Ended earlyNCT00901537
What this trial is testing

Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Loma Linda University 8
Testing effectiveness (Phase 2)Study completedNCT02207530
What this trial is testing

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 112
Large-scale testing (Phase 3)Looking for participantsNCT07264075
What this trial is testing

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Who this might be right for
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Groupe Oncologie Radiotherapie Tete et Cou 780
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Next Page